Neogen’s Paw Print Genetics Competitors

Embark is changing the way pet parents care for their dogs, from snout to tail, so they can enjoy more happy, healthy years together. Backed by industry-leading genetic research, Embark offers a suite of tools designed to help pet parents build a stronger bond with their pup. From DNA testing to supplements, Embark empowers pet parents to understand their dog’s unique needs and support their long-term health with confidence.

Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA. On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were not disclosed. “The addition of Basepaws will enhance our portfolio in the precision animal health space and inform our future pipeline of petcare innovations. Working together, we can continue to provide veterinarians and pet owners with more comprehensive ways to proactively manage the health, wellness and quality of care for their animals.” - said Zoetis CEO Kristin Peck.

Know your pet's whole story with the world's leading pet DNA test. As the most accurate pet DNA test on the market, Wisdom Panel™ helps you understand your pet on a deeper level with insights into breed mix, relatives, genetic health, and physical traits. With over 20+ years of experience in genetic testing and chosen by 4+ million pet parents, Wisdom Panel delivers insights so you can give your pet the best care. Every single test contributes to the largest veterinary genetic research study to help improve the lives of all pets.